Xudong Wu

机构：China Pharmaceutical University, Guangzhou Vocational College of Science and Technology, Nanjing Drum Tower Hospital, Yibin University, Pharmaceutical Biotechnology (Czechia), State Key Laboratory of Pharmaceutical Biotechnology, Tianjin Medical University, Nanjing University

发表论文 27 篇 · 总被引 801 次 · h-index 14

代表论文

• ALYREF mainly binds to the 5′ and the 3′ regions of the mRNA in vivo (2017 · Nucleic Acids Research · 被引 147)
• Exosome cofactor hMTR4 competes with export adaptor ALYREF to ensure balanced nuclear RNA pools for degradation and export (2017 · The EMBO Journal · 被引 112)
• Chemodivergent transformations of amides using gem-diborylalkanes as pro-nucleophiles (2020 · Nature Communications · 被引 77)
• ALYREF links 3′‐end processing to nuclear export of non‐polyadenylated mRNAs (2019 · The EMBO Journal · 被引 56)
• NRDE2 negatively regulates exosome functions by inhibiting MTR4 recruitment and exosome interaction (2019 · Genes & Development · 被引 53)
• Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice (2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 49)